Combining Genome-Wide Studies of Breast, Prostate, Ovarian and Endometrial Cancers Maps Cross-Cancer Susceptibility Loci and Identifies New Genetic Associations
Siddhartha Kar,Sara Lindström,Rayjean J. Hung,Kate Lawrenson,Marjanka K. Schmidt,Tracy A. O’Mara,Dylan M. Glubb,Jonathan Tyrer,Joellen M. Schildkraut,Jenny Chang‐Claude,Ahmad Alsulimani,Fernando Moreno Antón,Alicia Beeghly‐Fadiel,Line Bjørge,Clara Bodelón,Hiltrud Brauch,Stefanie Burghaus,Daniele Campa,Michael E. Carney,Chu Chen,Zhihua Chen,Mary B. Daly,Andreas du Bois,Arif B. Ekici,Ailith Ewing,Peter A. Fasching,James M. Flanagan,Jan Gawełko,Graham G. Giles,Robert J. Hamilton,Holly R. Harris,Florian Heitz,Michelle A.T. Hildebrandt,Peter Hillemanns,Ruea‐Yea Huang,Liher Imaz,Arvīds Irmejs,Anna Jakubowska,Allan Jensen,Esther M. John,Päivi Kannisto,Beth Y. Karlan,Elza Khusnutdinova,Lambertus A. Kiemeney,Susanne K. Kjær,Rüdiger Klapdor,Petra Kleiblová,Martin Köbel,B Konopka,Camilla Krakstad,Davor Lessel,Artitaya Lophatananon,Taymaa May,Agnieszka D. Mieszkowska,Alvaro N.A. Monteiro,Kirsten B. Moysich,Kenneth Muir,Sune F. Nielsen,Kunle Odunsi,Håkan Olsson,Tjoung‐Won Park‐Simon,Jennifer B. Permuth,Paolo Peterlongo,Agnieszka Podgorski,Ross L. Prentice,Paolo Radice,Harvey A. Risch,Ingo B. Runnebaum,Iwona K. Rzepecka,Rodney J. Scott,Veronica Wendy Setiawan,Nadeem Siddiqui,Weiva Sieh,Beata Śpiewankiewicz,Lukasz M. Szafron,Cheryl L. Thompson,Linda Titus,Catherine Huntley,Nawaid Usmani,Anne M. van Altena,Ana Vega‐Gliemmo,Ignace Vergote,Robert A. Vierkant,Joseph Vijai,Stacey J. Winham,Robert Winqvist,Herbert Yu,Diether Lambrechts,Deborah J. Thompson,Ellen L. Goode,Zheng Wang,Ian Tomlinson,Andrew Berchuck,Susan J. Ramus,Stephen J. Chanock,Douglas F. Easton,Georgia Chenevix‐Trench,Simon A. Gayther,Amanda B. Spurdle,Rosalind A. Eeles,Peter Kraft,Paul D.P. Pharoah
DOI: https://doi.org/10.1101/2020.06.16.146803
2020-01-01
Abstract:We report a meta-analysis of breast, prostate, ovarian, and endometrial cancer genome-wide association data (effective sample size: 237,483 cases/317,006 controls). This identified 465 independent lead variants (P<5×10−8) across 192 genomic regions. Four lead variants were >1Mb from previously identified risk loci for the four cancers and an additional 23 lead variant-cancer associations were novel for one of the cancers. Bayesian models supported pleiotropic effects involving at least two cancers at 222/465 lead variants in 118/192 regions. Gene-level association analysis identified 13 shared susceptibility genes (P<2.6×10−6) in 13 regions not previously implicated in any of the four cancers and not uncovered by our variant-level meta-analysis. Several lead variants had opposite effects across cancers, including a cluster of such variants in the TP53 pathway. Fifty-four lead variants were associated with blood cell traits and suggested genetic overlaps with clonal hematopoiesis. Our study highlights the remarkable pervasiveness of pleiotropy across hormone-related cancers, further illuminating their shared genetic and mechanistic origins at variant- and gene-level resolution.